Pelthos Therapeutics Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-19.
Pelthos Therapeutics Inc. filed a Form D notice of an exempt securities offering with the SEC on November 19, 2025. The filing reports $18M sold. Its industry group is Pharmaceuticals. It names Scott Plesha (Chief Executive Officer), Francis Knuettel II (Chief Financial Officer), Sai Rangarao (Chief Commercial Officer) (SEC Form D, November 19, 2025).
Is this your company?
Sell to companies like Pelthos Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pelthos Therapeutics Inc.
Free to see. No signup.
More on the people and the money behind Pelthos Therapeutics Inc., from the filings we hold.
Pharmaceuticals raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when Pelthos Therapeutics Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Pelthos Therapeutics Inc. raises, hires or launches. No email unless you switch it on.
Watch Pelthos Therapeutics Inc. →Get the full cited report on Pelthos Therapeutics Inc.
What the filing shows about Pelthos Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Pelthos Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Pelthos Therapeutics Inc.'s address as 4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Pelthos Therapeutics Inc. See pricing
Pelthos Therapeutics Inc. is a registered filer with the SEC (CIK 1919246) and has filed since 2024-08-06. 4 filings are on record, the latest on 2025-11-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Pelthos Therapeutics Inc.'s Form D of 2025-11-19 names Scott Plesha, Francis Knuettel II, Sai Rangarao and 6 more as its officers, directors or promoters.
Its new offerings report $68.85M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week. The dot is this raise, $18M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Scott Plesha is named as Chief Executive Officer on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Francis Knuettel II is named as Chief Financial Officer on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Sai Rangarao is named as Chief Commercial Officer on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
Richard Baxter is named as Director on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
Peter Greenleaf is named as Director on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
Ezra Friedberg is named as Director on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
Todd Davis is named as Director on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
Richard Malamut is named as Director on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
Matthew Pauls is named as Director on the Form D that Pelthos Therapeutics Inc. filed with the SEC on 19 November 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-11-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Pelthos Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Pelthos Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pelthos Therapeutics Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pelthos Therapeutics Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Pelthos Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Pelthos Therapeutics Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/pelthos-therapeutics-inc-form-d-25000001